Abstract 373: Circulating endothelial cell measurement allows early prediction of outcome in patients with metastatic colorectal cancer treated with first-line bevacizumab and chemotherapy. Findings from the FNCLCC ACCORD 13/0503 randomized phase II trial
Valerie Boige
◽
Jean Mendiboure
◽
Antoine Adenis
◽
Evelyne Boucher
◽
Jean-Yves Pierga
◽
...